Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

My Wife Took Tylenol While Pregnant—Should We Worry? Experts Explain

On September 22, 2025, President Donald Trump released a statement suggesting that Tylenol was linked to an increased risk of autism when used by pregnant mothers. He urged pregnant women to stop taking the drug. “Don’t take Tylenol,” Trump said. “Fight like hell not to take it.” On the same…

Clever Dude

Merck, Doctors Reject Proposal To Break Up Combined MMR Vaccine

A top U.S. health official's call to split the measles-mumps-rubella (MMR) vaccine into separate shots sparked strong pushback from Merck Co., Inc. (NYSE:MRK) and medical experts, who said such a move lacks scientific justification and could undermine immunization efforts.

Benzinga

This Emerging Biotech Stock Jumped 1,300% on Monday After Major FDA Breakthrough Milestone

Spruce Biosciences' stock surged to record highs after it received an FDA breakthrough designation for the TA-ERT candidate to treat a rare genetic disease.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2

Adicet Bio Inc. (NASDAQ:ACET) shares fell Tuesday after the biotechnology company priced an $80 million direct offering, even as early safety and efficacy data from its Phase 1 trial of ADI-001 in autoimmune diseases showed encouraging signs.

Benzinga

EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial

Envoy Medical Inc. (NASDAQ:COCH) announced on Tuesday that it has received U.S. Food and Drug Administration (FDA) approval to expand its pivotal clinical trial for the fully implanted Acclaim cochlear implant to the final stage, based on promising three-month data from the first 10 patients.

Benzinga

Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here's Why

Spruce Biosciences Inc. (NASDAQ:SPRB) jumped to $175.00 during after-hours trading on Monday, up 34.20% or $44.60 from its closing price.

Benzinga

Here Are 10 Things You Need to Know About GMO Fruit

Whether you love them or avoid them, genetically modified fruits—better known as GMOs—have become impossible to ignore. From apples that don’t brown to papayas that resist disease, GMO fruit has quietly made its way onto grocery store shelves around the world. Yet confusion remains high, and misinformation spreads faster than…

Grocery Coupon Guide

Read news from The Economist, FT, and more,
with one subscription

What the Government Shutdown Means to Retirees

Depending upon how long it lasts, a government shutdown can impact your daily life, including seeing family, managing your health, and enjoying your free time.

Kiplinger

Kroger premade pasta salads sold in 28 states under recall over Listeria concerns

There have been no reports of illness stemming from the recall

The Independent UK

AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy

AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo on Monday released high-level results from the TROPION-Breast02 Phase 3 trial.

Benzinga

QURE: Why Analysts See Up to 63% Upside After 250% Single-Day Pop

Biotech stock uniQure just popped nearly 250% in one day, with an analyst calling its trial results "amazing". Wall Street sees significant upside to come.

MarketBeat

Samsung Galaxy Watches will 'soon' detect warning signs for heart failure

Apple made a splash with hypertension alerts; now Samsung will tackle its own serious health condition: Heart failure.

Android Central

I wore the Circular Ring 2 for three weeks and wanted to love it — but one big thing held it back

The Circular Ring 2 is a long-lasting, subscription-free smart ring with advanced, holistic tools like ECG readings, blood oxygen monitoring, and AFib detection but a buggy app limits its appeal for now.

Tom’s Guide

Anti-abortion groups furious as FDA approves generic abortion pill

Abortion rights supporters hail win for evidence-backed medicine as Evita Solutions’ generic version of mifepristone given approval

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Trump administration approves generic version of abortion pill after RFK Jr had FDA review drug’s safety

The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’

Kiplinger

The Best Biotech ETFs to Buy

Biotech ETFs offer investors exposure to the most innovative and growth-oriented industry within the traditionally defensive healthcare sector.

Axios

Conservatives rage after FDA approves generic abortion drug

The decision adds to conservative scrutiny of the agency and Commissioner Marty Makary.

Benzinga

Top 2 Health Care Stocks That May Keep You Up At Night This Month

As of Oct. 2, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Mountain Dew, Gatorade and Cheetos to undergo makeover amid health fears

PepsiCo is looking at purple sweet potatoes and carrots to color drinks like Mountain Dew and Cherry 7Up

The Independent UK

The frozen fruit was sold in retailers across the U.S.

Benzinga

Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?

Shares of Tempus AI Inc (NASDAQ:TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here’s what investors need to know.

Benzinga

EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions

Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing organization (GPO) agreements for its new drug, Arbli (losartan potassium) Oral Suspension, 10 mg/mL.

The Independent UK

Walmart sets a timeline for removing synthetic dyes and other additives from its food brands

Walmart says it plans to remove synthetic dyes and 30 other food additives from its store brands sold in the United States by January 2027

The Guardian - US

Federal agencies blame Democrats for looming shutdown in apparent Hatch Act violation

Housing and VA departments attack ‘radical left’ despite law limiting political activities of government employees

Reason

Can Americans Trust RFK Jr.'s Health Advice? A Breakdown on Vaccines, Autism, Food Dyes, and More

As ever, be cautious about what you hear from the Department of Health and Human Services.

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.